Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7523

1.

The emerging role of microRNAs in Alzheimer's disease.

Femminella GD, Ferrara N, Rengo G.

Front Physiol. 2015 Feb 12;6:40. doi: 10.3389/fphys.2015.00040. eCollection 2015. Review.

PMID:
25729367
[PubMed]
2.

Reversible redox modifications in the microglial proteome challenged by beta amyloid.

Correani V, Francesco LD, Cera I, Mignogna G, Giorgi A, Mazzanti M, Fumagalli L, Fabrizi C, Maras B, Schininà ME.

Mol Biosyst. 2015 Mar 2. [Epub ahead of print]

PMID:
25728364
[PubMed - as supplied by publisher]
3.

Clinical and imaging features of mixed Alzheimer and vascular pathologies.

Chui HC, Ramirez-Gomez L.

Alzheimers Res Ther. 2015 Feb 27;7(1):21. doi: 10.1186/s13195-015-0104-7. eCollection 2015.

PMID:
25722748
[PubMed]
Free PMC Article
4.

Circulating Biomarker Panels in Alzheimer's Disease.

Zafari S, Backes C, Meese E, Keller A.

Gerontology. 2015 Feb 25. [Epub ahead of print]

PMID:
25720553
[PubMed - as supplied by publisher]
5.

Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.

Herukka SK, Rummukainen J, Ihalainen J, von Und Zu Fraunberg M, Koivisto AM, Nerg O, Puli LK, Seppälä TT, Zetterberg H, Pyykkö OT, Helisalmi S, Tanila H, Alafuzoff I, Hiltunen M, Rinne J, Soininen H, Jääskeläinen JE, Leinonen V.

J Alzheimers Dis. 2015 Feb 26. [Epub ahead of print]

PMID:
25720406
[PubMed - as supplied by publisher]
6.

An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in APOE4-Negative Mild Cognitive Impairment Patients.

Sun Y, Bresell A, Rantalainen M, Höglund K, Lebouvier T, Salter H.

J Alzheimers Dis. 2015 Feb 26. [Epub ahead of print]

PMID:
25720397
[PubMed - as supplied by publisher]
7.

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications.

Bros P, Delatour V, Vialaret J, Lalere B, Barthelemy N, Gabelle A, Lehmann S, Hirtz C.

Clin Chem Lab Med. 2015 Feb 18. pii: /j/cclm.ahead-of-print/cclm-2014-1048/cclm-2014-1048.xml. doi: 10.1515/cclm-2014-1048. [Epub ahead of print]

PMID:
25719328
[PubMed - as supplied by publisher]
8.

Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.

Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, Fagan AM, Morris JC, Ances BM.

Neurology. 2015 Feb 25. pii: 10.1212/WNL.0000000000001401. [Epub ahead of print]

PMID:
25716355
[PubMed - as supplied by publisher]
9.

Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI.

Wolfsgruber S, Jessen F, Koppara A, Kleineidam L, Schmidtke K, Frölich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Pantel J, Rienhoff O, Rüther E, Henn F, Wiltfang J, Maier W, Kornhuber J, Wagner M.

Neurology. 2015 Feb 25. pii: 10.1212/WNL.0000000000001399. [Epub ahead of print]

PMID:
25716354
[PubMed - as supplied by publisher]
10.

Fitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementia.

Mar J, Soto-Gordoa M, Arrospide A, Moreno-Izco F, Martínez-Lage P.

Alzheimers Res Ther. 2015 Jan 15;7(1):2. doi: 10.1186/s13195-014-0079-9. eCollection 2015.

PMID:
25713598
[PubMed]
Free PMC Article
11.

The biomarker and therapeutic potential of miRNA in Alzheimer's disease.

Bekris LM, Leverenz JB.

Neurodegener Dis Manag. 2015 Feb;5(1):61-74. doi: 10.2217/nmt.14.52.

PMID:
25711455
[PubMed - in process]
12.

Mild cognitive impairment definitions: more evolution than revolution.

Tang EY, Brayne C, Albanese E, Stephan BC.

Neurodegener Dis Manag. 2015 Feb;5(1):11-7. doi: 10.2217/nmt.14.42.

PMID:
25711450
[PubMed - in process]
13.

Cerebrospinal Fluid β-Amyloid1-42 Levels in the Differential Diagnosis of Alzheimer's Disease-Systematic Review and Meta-Analysis.

Mo JA, Lim JH, Sul AR, Lee M, Youn YC, Kim HJ.

PLoS One. 2015 Feb 24;10(2):e0116802. doi: 10.1371/journal.pone.0116802. eCollection 2015.

PMID:
25710596
[PubMed - in process]
Free Article
14.

A γ-Secretase Inhibitor, but Not a γ-Secretase Modulator, Induced Defects in BDNF Axonal Trafficking and Signaling: Evidence for a Role for APP.

Weissmiller AM, Natera-Naranjo O, Reyna SM, Pearn ML, Zhao X, Nguyen P, Cheng S, Goldstein LS, Tanzi RE, Wagner SL, Mobley WC, Wu C.

PLoS One. 2015 Feb 24;10(2):e0118379. doi: 10.1371/journal.pone.0118379. eCollection 2015.

PMID:
25710492
[PubMed - in process]
Free Article
15.

Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease.

Bishnoi RJ, Palmer RF, Royall DR.

PLoS One. 2015 Feb 24;10(2):e0117282. doi: 10.1371/journal.pone.0117282. eCollection 2015.

PMID:
25710473
[PubMed - in process]
Free Article
16.

Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers.

Gordon BA, Zacks JM, Blazey T, Benzinger TL, Morris JC, Fagan AM, Holtzman DM, Balota DA.

Neurobiol Aging. 2015 Jan 29. pii: S0197-4580(15)00052-4. doi: 10.1016/j.neurobiolaging.2015.01.019. [Epub ahead of print]

PMID:
25708908
[PubMed - as supplied by publisher]
17.

Discrimination of mild cognitive impairment and Alzheimer's disease using transfer entropy measures of scalp EEG.

McBride J, Zhao X, Munro N, Jicha G, Smith C, Jiang Y.

J Healthc Eng. 2015;6(1):55-70. doi: 10.1260/2040-2295.6.1.55.

PMID:
25708377
[PubMed - in process]
18.

Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis.

Luo X, Shi H, Hou L, Zhong X, Chen X, Zhang Y, Zheng D, Tan Y, Hu G, Mu N, Chen J, Fang Y, He H, Ning Y.

Eur J Neurol. 2015 Feb 23. doi: 10.1111/ene.12680. [Epub ahead of print]

PMID:
25707998
[PubMed - as supplied by publisher]
19.

Predictive structural dynamic network analysis.

Chen R, Herskovits EH; the Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2015 Feb 20. pii: S0165-0270(15)00063-1. doi: 10.1016/j.jneumeth.2015.02.011. [Epub ahead of print]

PMID:
25707306
[PubMed - as supplied by publisher]
20.

Extracellular vesicles - Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases.

Coleman BM, Hill AF.

Semin Cell Dev Biol. 2015 Feb 20. pii: S1084-9521(15)00034-8. doi: 10.1016/j.semcdb.2015.02.007. [Epub ahead of print] Review.

PMID:
25704308
[PubMed - as supplied by publisher]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk